Insulin efsitora alfa for treating type 1 diabetes in people on multiple daily insulin injections [ID6498]

  • In development
  • GID-TA11645
  • Expected publication date: TBC

Suggested remit: To appraise the clinical and cost effectiveness of Insulin efsitora alfa within its marketing authorisation for treating type 1 diabetes in people on multiple daily insulin injections